Search research articles
Contact Us
Filters
Showing results (81-90 of 120) with videos related to
Page
of 12
Sort By:
Leukemia Research
|
September 10, 2013
Phase II trial of clofarabine and daunorubicin as induction therapy for acute myeloid leukemia patients greater than or equal to 60 years of age
Carlos E Vigil, Wei Tan, George Deeb, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 22, 2013
Subcutaneous omacetaxine mepesuccinate in patients with chronic-phase chronic myeloid leukemia previously treated with 2 or more tyrosine kinase inhibitors including imatinib
Jorge E Cortes, Franck E Nicolini, Meir Wetzler, et al.
Molecular Cancer Therapeutics
|
October 7, 2010
Aflibercept exerts antivascular effects and enhances levels of anthracycline chemotherapy in vivo in human acute myeloid leukemia models
Deepika Lal, Jennifer A Park, Kellie Demock, et al.
Transplantation
|
December 16, 2004
Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletion
Theresa Hahn, Arif Raza Alam, David Lawrence, et al.
Leukemia Research
|
May 23, 2013
Myelodysplastic syndromes and autoimmune diseases--case series and review of literature
Omar Al Ustwani, Laurie A Ford, Sheila J N Sait, et al.
Blood
|
March 22, 2007
Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission
Martin S Tallman, Gordon W Dewald, Sharavi Gandham, et al.
Haematologica
|
October 1, 2013
Autologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (Alliance)
Meir Wetzler, Dorothy Watson, Wendy Stock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2009
High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responses
Jorge E Cortes, Hagop M Kantarjian, Stuart L Goldberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2010
Control of plasma uric acid in adults at risk for tumor Lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone--results of a multicenter phase III study
Jorge Cortes, Joseph O Moore, Richard T Maziarz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 24, 2006
Arsenic trioxide affects signal transducer and activator of transcription proteins through alteration of protein tyrosine kinase phosphorylation
Meir Wetzler, Michael T Brady, Erin Tracy, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 120) with videos related to
Sort By:
Page
of 12
Leukemia Research
|
September 10, 2013
Phase II trial of clofarabine and daunorubicin as induction therapy for acute myeloid leukemia patients greater than or equal to 60 years of age
Carlos E Vigil, Wei Tan, George Deeb, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 22, 2013
Subcutaneous omacetaxine mepesuccinate in patients with chronic-phase chronic myeloid leukemia previously treated with 2 or more tyrosine kinase inhibitors including imatinib
Jorge E Cortes, Franck E Nicolini, Meir Wetzler, et al.
Molecular Cancer Therapeutics
|
October 7, 2010
Aflibercept exerts antivascular effects and enhances levels of anthracycline chemotherapy in vivo in human acute myeloid leukemia models
Deepika Lal, Jennifer A Park, Kellie Demock, et al.
Transplantation
|
December 16, 2004
Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletion
Theresa Hahn, Arif Raza Alam, David Lawrence, et al.
Leukemia Research
|
May 23, 2013
Myelodysplastic syndromes and autoimmune diseases--case series and review of literature
Omar Al Ustwani, Laurie A Ford, Sheila J N Sait, et al.
Blood
|
March 22, 2007
Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission
Martin S Tallman, Gordon W Dewald, Sharavi Gandham, et al.
Haematologica
|
October 1, 2013
Autologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (Alliance)
Meir Wetzler, Dorothy Watson, Wendy Stock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2009
High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responses
Jorge E Cortes, Hagop M Kantarjian, Stuart L Goldberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2010
Control of plasma uric acid in adults at risk for tumor Lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone--results of a multicenter phase III study
Jorge Cortes, Joseph O Moore, Richard T Maziarz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 24, 2006
Arsenic trioxide affects signal transducer and activator of transcription proteins through alteration of protein tyrosine kinase phosphorylation
Meir Wetzler, Michael T Brady, Erin Tracy, et al.
Page
of 12